Immunoaffinity techniques coupled to mass spectrometry for the analysis of human peptide hormones: advances and applications

References

• Bults P, van de Merbel NC, Bischoff R. Quantification of biopharmaceuticals and biomarkers in complex biological matrices: a comparison of liquid chromatography coupled to tandem mass spectrometry and ligand binding assays. Expert Rev Proteomics. 2015;12:355–374.
   PubMed Web of Science ®Google Scholar
• Laha TJ, Strathmann FG, Wang Z, et al. Characterizing antibody cross-reactivity for immunoaffinity purification of analytes prior to multiplexed liquid chromatography-tandem mass spectrometry. Clin Chem. 2012;58:1711–1716.
   PubMed Web of Science ®Google Scholar
• Tighe PJ, Ryder RR, Todd I, et al. ELISA in the multiplex era: potentials and pitfalls. Proteomics Clin Appl. 2015;9:406–422.
   PubMed Web of Science ®Google Scholar
• Hoofnagle AN, Wener MH. The fundamental flaws of immunoassays and potential solutions using tandem mass spectrometry. J Immunol Methods. 2009;347:3–11.
   PubMed Web of Science ®Google Scholar
• Ackermann BL. Immunoaffinity MS: adding increased value through hybrid methods. Bioanalysis. 2016;8:1535–1537.
   PubMed Web of Science ®Google Scholar
• Whiteaker JR, Paulovich AG. Peptide immunoaffinity enrichment coupled with mass spectrometry for peptide and protein quantification. Clin Lab Med. 2011;31:385–396.
   PubMed Web of Science ®Google Scholar
• Ackermann BL, Berna MJ. Coupling immunoaffinity techniques with MS for quantitative analysis of low-abundance protein biomarkers. Expert Rev Proteomics. 2007;4:175–186.
   PubMed Web of Science ®Google Scholar
• Thomas A, Geyer H, Kamber M, et al. Mass spectrometric determination of gonadotrophin-releasing hormone (GnRH) in human urine for doping control purposes by means of LC-ESI-MS/MS. J Mass Spectrom. 2008;43:908–915.
   PubMed Web of Science ®Google Scholar
• Shimazaki Y, Takatsu Y. Combined method of immunoaffinity membrane within tubes and MALDI-TOF MS for capturing and analyzing amyloid beta. Appl Biochem Biotechnol. 2015;177:1565–1571.
   PubMed Web of Science ®Google Scholar
• Thomas A, Brinkkötter P, Schänzer W, et al. Simultaneous determination of insulin, DesB30 insulin, proinsulin, and C-peptide in human plasma samples by liquid chromatography coupled to high resolution mass spectrometry. Forensic Toxicol. 2016;35:106–113.
   Web of Science ®Google Scholar
• Schoenherr RM, Zhao L, Whiteaker JR, et al. Automated screening of monoclonal antibodies for SISCAPA assays using a magnetic bead processor and liquid chromatography-selected reaction monitoring-mass spectrometry. J Immunol Methods. 2010;353:49–61.
   PubMed Web of Science ®Google Scholar
• Faria M, Halquist MS, Yuan M, et al. Comparison of a stable isotope labeled (SIL) peptide and an extended SIL peptide as internal standards to track digestion variability of an unstable signature peptide during quantification of a cancer biomarker, human osteopontin, from plasma using capillary microflow LC-MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci. 2015;1001:156–168.
   PubMed Web of Science ®Google Scholar
• Whiteaker JR, Zhao L, Zhang HY, et al. Antibody-based enrichment of peptides on magnetic beads for mass-spectrometry-based quantification of serum biomarkers. Anal Biochem. 2007;362:44–54.
   PubMed Web of Science ®Google Scholar
• Bostrom T, Takanen JO, Hober S. Antibodies as means for selective mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2016;1021:3–13.
   PubMed Web of Science ®Google Scholar
• Schoenherr RM, Zhao L, Ivey RG, et al. Commercially available antibodies can be applied in quantitative multiplexed peptide immunoaffinity enrichment targeted mass spectrometry assays. Proteomics. 2016;16:2141–2145.
   PubMed Web of Science ®Google Scholar
• Vogel M, Thomas A, Schänzer W, et al. EPOR-based purification and analysis of erythropoietin mimetic peptides from human urine by cys-specific cleavage and LC/MS/MS. J Am Soc Mass Spectrom. 2015 Sep;26(9):1617-1625.
   Google Scholar
• Saeed AF, Wang R, Ling S, et al. Antibody engineering for pursuing a healthier future. Front Microbiol. 2017;8:495.
   PubMed Web of Science ®Google Scholar
• Becker JO, Hoofnagle AN. Replacing immunoassays with tryptic digestion-peptide immunoaffinity enrichment and LC-MS/MS. Bioanalysis. 2012;4:281–290.
   PubMed Web of Science ®Google Scholar
• Lund H, Torsetnes SB, Paus E, et al. Exploring the complementary selectivity of immunocapture and MS detection for the differentiation between hCG isoforms in clinically relevant samples. J Proteome Res. 2009;8:5241–5252.
   PubMed Web of Science ®Google Scholar
• Torsetnes SB, Lovbak SG, Claus C, et al. Immunocapture and LC-MS/MS for selective quantification and differentiation of the isozymes of the biomarker neuron-specific enolase in serum. J Chromatogr B Analyt Technol Biomed Life Sci. 2013;929:125–132.
   PubMed Web of Science ®Google Scholar
• Thomas A, Schänzer W, Delahaut P, et al. Immunoaffinity purification of peptide hormones prior to liquid chromatography-mass spectrometry in doping controls. Methods. 2012;56:230–235.
   PubMed Web of Science ®Google Scholar
• Thomas A, Walpurgis K, Tretzel L, et al. Expanded test method for peptides >2 kDa employing immunoaffinity purification and LC-HRMS/MS. Drug Test Anal. 2015;7:990–998.
   PubMed Web of Science ®Google Scholar
• Whiteaker JR, Zhao L, Yan P, et al. Peptide immunoaffinity enrichment and targeted mass spectrometry enables multiplex, quantitative pharmacodynamic studies of phospho-signaling. Mol Cell Proteomics. 2015;14:2261–2273.
   PubMed Web of Science ®Google Scholar
• Edfors F, Bostrom T, Forsstrom B, et al. Immunoproteomics using polyclonal antibodies and stable isotope-labeled affinity-purified recombinant proteins. Mol Cell Proteomics. 2014;13:1611–1624.
   PubMed Web of Science ®Google Scholar
• Hoofnagle AN. Peptide lost and found: internal standards and the mass spectrometric quantification of peptides. Clin Chem. 2010;56:1515–1517.
   PubMed Web of Science ®Google Scholar
• Arsene CG, Kratzsch J, Henrion A. Mass spectrometry - an alternative in growth hormone measurement. Bioanalysis. 2014;6:2391–2402.
   PubMed Web of Science ®Google Scholar
• Green RP, Hollander AS, Thevis M, et al. Detection of surreptitious administration of analog insulin to an 8-week-old infant. Pediatrics. 2010;125:e1236–e1240.
   PubMed Web of Science ®Google Scholar
• Henderson CM, Bollinger JG, Becker JO, et al. Quantification by nano liquid chromatography parallel reaction monitoring mass spectrometry of human apolipoprotein A-I, apolipoprotein B, and hemoglobin A1c in dried blood spots. Proteomics Clin Appl. 2017 Jul;11(7-8). doi: 10.1002/prca.201600103.
   Google Scholar
• Hess C, Thomas A, Thevis M, et al. Simultaneous determination and validated quantification of human insulin and its synthetic analogues in human blood serum by immunoaffinity purification and liquid chromatography-mass spectrometry. Anal Bioanal Chem. 2012;404:1813–1822.
   PubMed Web of Science ®Google Scholar
• Hoofnagle AN, Becker JO, Wener MH, et al. Quantification of thyroglobulin, a low-abundance serum protein, by immunoaffinity peptide enrichment and tandem mass spectrometry. Clin Chem. 2008;54:1796–1804.
   PubMed Web of Science ®Google Scholar
• Kemna EH, Tjalsma H, Podust VN, et al. Mass spectrometry-based hepcidin measurements in serum and urine: analytical aspects and clinical implications. Clin Chem. 2007;53:620–628.
   PubMed Web of Science ®Google Scholar
• Kumar V, Barnidge DR, Chen LS, et al. Quantification of serum 1-84 parathyroid hormone in patients with hyperparathyroidism by immunocapture in situ digestion liquid chromatography-tandem mass spectrometry. Clin Chem. 2010;56:306–313.
   PubMed Web of Science ®Google Scholar
• Möller I, Thomas A, Delahaut P, et al. Mass spectrometric detection of peginesatide in human urine in doping control analysis. J Pharm Biomed Anal. 2012 Nov;70:512-517.
   Google Scholar
• Ocana MF, Neubert H. An immunoaffinity liquid chromatography-tandem mass spectrometry assay for the quantitation of matrix metalloproteinase 9 in mouse serum. Anal Biochem. 2010;399:202–210.
   PubMed Web of Science ®Google Scholar
• Ojanpera I, Sajantila A, Vinogradova L, et al. Post-mortem vitreous humour as potential specimen for detection of insulin analogues by LC-MS/MS. Forensic Sci Int. 2013;233:328–332.
   PubMed Web of Science ®Google Scholar
• Rossetti C, Levernaes MC, Reubsaet L, et al. Evaluation of affinity-based serum clean-up in mass spectrometric analysis: plastic vs monoclonal antibodies. J Chromatogr A. 2016;1471:19–26.
   PubMed Web of Science ®Google Scholar
• Schoenherr RM, Whiteaker JR, Zhao L, et al. Multiplexed quantification of estrogen receptor and HER2/Neu in tissue and cell lysates by peptide immunoaffinity enrichment mass spectrometry. Proteomics. 2012;12:1253–1260.
   PubMed Web of Science ®Google Scholar
• Thanawala N, Cheney S, Wark G, et al. Factitious administration of analogue insulin to a 2-year-old child. Br J Diabetes. 2016;16:82–84.
   Web of Science ®Google Scholar
• Whiteaker JR, Zhao L, Abbatiello SE, et al. Evaluation of large scale quantitative proteomic assay development using peptide affinity-based mass spectrometry. Mol Cell Proteomics. 2011;10:M110 005645.
   PubMed Web of Science ®Google Scholar
• Winther B, Nordlund M, Paus E, et al. Immuno-capture as ultimate sample cleanup in LC-MS/MS determination of the early stage biomarker ProGRP. J Sep Sci. 2009;32:2937–2943.
   PubMed Web of Science ®Google Scholar
• Xu Q, Zhu M, Yang T, et al. Quantitative assessment of human serum transferrin receptor in breast cancer patients pre- and post-chemotherapy using peptide immunoaffinity enrichment coupled with targeted proteomics. Clin Chim Acta. 2015;448:118–123.
   PubMed Web of Science ®Google Scholar
• Zhao L, Whiteaker JR, Pope ME, et al. Quantification of proteins using peptide immunoaffinity enrichment coupled with mass spectrometry. J Vis Exp. 2011 Jul 31;(53). pii: 2812. doi: 10.3791/2812.
   Google Scholar
• Kelley M, Ahene AB, Gorovits B, et al. Theoretical considerations and practical approaches to address the effect of anti-drug antibody (ADA) on quantification of biotherapeutics in circulation. AAPS J. 2013;15:646–658.
   PubMed Web of Science ®Google Scholar
• Thomas A, Thevis M, Delahaut P, et al. Mass spectrometric identification of degradation products of insulin and its long-acting analogues in human urine for doping control purposes. Anal Chem. 2007;79:2518–2524.
   PubMed Web of Science ®Google Scholar
• Kuuranne T, Thomas A, Leinonen A, et al. Insulins in equine urine: qualitative analysis by immunoaffinity purification and liquid chromatography/tandem mass spectrometry for doping control purposes in horse-racing. Rapid Commun Mass Spectrom. 2008;22:355–362.
   PubMed Web of Science ®Google Scholar
• Kohler M, Thomas A, Puschel K, et al. Identification of human pituitary growth hormone variants by mass spectrometry. J Proteome Res. 2009;8:1071–1076.
   PubMed Web of Science ®Google Scholar
• Thomas A, Kohler M, Schänzer W, et al. Determination of Synacthen in urine for sports drug testing by means of nano-ultra-performance liquid chromatography/tandem mass spectrometry. Rapid Commun Mass Spectrom. 2009;23:2669–2674.
   PubMed Web of Science ®Google Scholar
• Thomas A, Schänzer W, Delahaut P, et al. Sensitive and fast identification of urinary human, synthetic and animal insulin by means of nano-UPLC coupled with high-resolution/high-accuracy mass spectrometry. Drug Test Anal. 2009;1:219–227.
   PubMed Web of Science ®Google Scholar
• Möller I, Thomas A, Geyer H, et al. Synthesis, characterisation, and mass spectrometric detection of a pegylated EPO-mimetic peptide for sports drug testing purposes. Rapid Commun Mass Spectrom. 2011;25:2115–2123.
   PubMed Web of Science ®Google Scholar
• Walpurgis K, Thomas A, Laussmann T, et al. Identification of fibroblast growth factor 1 (FGF-1) in a black market product. Drug Test Anal. 2011 Nov-Dec;3(11-12):791-797.
   Google Scholar
• Kuhn E, Whiteaker JR, Mani DR, et al. Interlaboratory evaluation of automated, multiplexed peptide immunoaffinity enrichment coupled to multiple reaction monitoring mass spectrometry for quantifying proteins in plasma. Mol Cell Proteomics. 2012;11:M111 013854.
   PubMed Web of Science ®Google Scholar
• Vogel M, Blobel M, Thomas A, et al. Isolation, enrichment and analysis of erythropoietins in anti-doping analysis by receptor-coated magnetic beads and liquid chromatography-mass spectrometry. Anal Chem. 2014 Dec 16;86(24):12014-12021.
   Google Scholar
• Thomas A, Brinkkötter P, Schänzer W, et al. Metabolism of human insulin after subcutaneous administration: a possible means to uncover insulin misuse. Anal Chim Acta. 2015;897:53–61.
   PubMed Web of Science ®Google Scholar
• Knoop A, Thomas A, Fichant E, et al. Qualitative identification of growth hormone-releasing hormones in human plasma by means of immunoaffinity purification and LC-HRMS/MS. Anal Bioanal Chem. 2016;408:3145–3153.
   PubMed Web of Science ®Google Scholar
• Walpurgis K, Thomas A, Vogel M, et al. Testing for the erythropoiesis-stimulating agent Sotatercept/ACE-011 (ActRIIA-Fc) in serum by means of western blotting and LC-HRMS. Drug Test Anal. 2016 Nov;8(11-12):1152-1161.
   Google Scholar
• Anderson NL, Anderson NG, Haines LR, et al. Mass spectrometric quantitation of peptides and proteins using stable isotope standards and capture by anti-peptide antibodies (SISCAPA). J Proteome Res. 2004;3:235–244.
   PubMed Web of Science ®Google Scholar
• Van Den Broek I, Nouta J, Razavi M, et al. Quantification of serum apolipoproteins A-I and B-100 in clinical samples using an automated SISCAPA-MALDI-TOF-MS workflow. Methods. 2015;81:74–85.
   PubMed Web of Science ®Google Scholar
• Razavi M, Leigh Anderson N, Pope ME, et al. High precision quantification of human plasma proteins using the automated SISCAPA immuno-MS workflow. N Biotechnol. 2016;33:494–502.
   PubMed Web of Science ®Google Scholar
• Razavi M, Johnson LD, Lum JJ, et al. Quantification of a proteotypic peptide from protein C inhibitor by liquid chromatography-free SISCAPA-MALDI mass spectrometry: application to identification of recurrence of prostate cancer. Clin Chem. 2013;59:1514–1522.
   PubMed Web of Science ®Google Scholar
• Razavi M, Frick LE, LaMarr WA, et al. High-throughput SISCAPA quantitation of peptides from human plasma digests by ultrafast, liquid chromatography-free mass spectrometry. J Proteome Res. 2012;11:5642–5649.
   PubMed Web of Science ®Google Scholar
• Razavi M, Anderson NL, Yip R, et al. Multiplexed longitudinal measurement of protein biomarkers in DBS using an automated SISCAPA workflow. Bioanalysis. 2016;8:1597–1609.
   PubMed Web of Science ®Google Scholar
• Kuhn E, Carr SA. Multiplexed immunoaffinity enrichment of peptides with anti-peptide antibodies and quantification by stable isotope dilution multiple reaction monitoring mass spectrometry. Methods Mol Biol. 2016;1410:135–167.
   PubMedGoogle Scholar
• Pritchard C, Groves KJ, Biesenbruch S, et al. Quantification of human growth hormone in serum with a labeled protein as an internal standard: essential considerations. Anal Chem. 2014;86:6525–6532.
   PubMed Web of Science ®Google Scholar
• Smits NG, Blokland MH, Wubs KL, et al. Monolith immuno-affinity enrichment liquid chromatography tandem mass spectrometry for quantitative protein analysis of recombinant bovine somatotropin in serum. Anal Bioanal Chem. 2015;407:6041–6050.
   PubMed Web of Science ®Google Scholar
• Neubert H, Gale J, Muirhead D. Online high-flow peptide immunoaffinity enrichment and nanoflow LC-MS/MS: assay development for total salivary pepsin/pepsinogen. Clin Chem. 2010;56:1413–1423.
   PubMed Web of Science ®Google Scholar
• Möller I, Thomas A, Geyer H, et al. Development and validation of a mass spectrometric detection method of peginesatide in dried blood spots for sports drug testing. Anal Bioanal Chem. 2012 Jul;403(9):2715-2724.
   Google Scholar
• Thevis M, Thomas A, Geyer H, et al. Mass spectrometric characterization of a biotechnologically produced full-length mechano growth factor (MGF) relevant for doping controls. Growth Horm IGF Res. 2014;24:276–280.
   PubMed Web of Science ®Google Scholar
• Thevis M, Thomas A, Schänzer W, et al. Measuring insulin in human vitreous humour using LC-MS/MS. Drug Test Anal. 2012;4:53–56.
   PubMed Web of Science ®Google Scholar
• Thomas A, Kohler M, Schänzer W, et al. Determination of IGF-1 and IGF-2, their degradation products and synthetic analogues in urine by LC-MS/MS. Analyst. 2011;136:1003–1012.
   PubMed Web of Science ®Google Scholar
• Thomas A, Schänzer W, Thevis M. Determination of human insulin and its analogues in human blood using liquid chromatography coupled to ion mobility mass spectrometry (LC-IM-MS). Drug Test Anal. 2014;6:1125–1132.
   PubMed Web of Science ®Google Scholar
• Vogel M, Dib J, Tretzel L, et al. Analytics of nonpeptidic erythropoietin mimetic agents in sports drug testing employing high-resolution/high-accuracy liquid chromatography-mass spectrometry. Anal Bioanal Chem. 2016;408:6431–6442.
   PubMed Web of Science ®Google Scholar
• Trenchevska O, Nelson RW, Nedelkov D. Mass spectrometric immunoassays for discovery, screening and quantification of clinically relevant proteoforms. Bioanalysis. 2016;8:1623–1633.
   PubMed Web of Science ®Google Scholar
• Trenchevska O, Nelson RW, Nedelkov D. Mass spectrometric immunoassays in characterization of clinically significant proteoforms. Proteomes. 2016 Mar 17;4(1). pii: E13. doi: 10.3390/proteomes4010013.
   Google Scholar
• Dufield DR, Radabaugh MR. Online immunoaffinity LC/MS/MS. A general method to increase sensitivity and specificity: how do you do it and what do you need? Methods. 2012;56:236–245.
   PubMed Web of Science ®Google Scholar
• Berna M, Schmalz C, Duffin K, et al. Online immunoaffinity liquid chromatography/tandem mass spectrometry determination of a type II collagen peptide biomarker in rat urine: investigation of the impact of collision-induced dissociation fluctuation on peptide quantitation. Anal Biochem. 2006;356:235–243.
   PubMed Web of Science ®Google Scholar
• Lee AY, Chappell DL, Bak MJ, et al. Multiplexed quantification of proglucagon-derived peptides by immunoaffinity enrichment and tandem mass spectrometry after a meal tolerance test. Clin Chem. 2016;62:227–235.
   PubMed Web of Science ®Google Scholar
• Lassman ME, McAvoy T, Lee AY, et al. Practical immunoaffinity-enrichment LC-MS for measuring protein kinetics of low-abundance proteins. Clin Chem. 2014;60:1217–1224.
   PubMed Web of Science ®Google Scholar
• Chappell DL, Lee AY, Castro-Perez J, et al. An ultrasensitive method for the quantitation of active and inactive GLP-1 in human plasma via immunoaffinity LC-MS/MS. Bioanalysis. 2014;6:33–42.
   PubMed Web of Science ®Google Scholar
• Ippoliti PJ, Kuhn E, Mani DR, et al. Automated microchromatography enables multiplexing of immunoaffinity enrichment of peptides to greater than 150 for targeted MS-based assays. Anal Chem. 2016;88:7548–7555.
   PubMed Web of Science ®Google Scholar
• Chin CF, Ler LW, Choong YS, et al. Application of streptavidin mass spectrometric immunoassay tips for immunoaffinity based antibody phage display panning. J Microbiol Methods. 2016;120:6–14.
   PubMed Web of Science ®Google Scholar
• Kiernan UA, Tubbs KA, Gruber K, et al. High-throughput protein characterization using mass spectrometric immunoassay. Anal Biochem. 2002;301:49–56.
   PubMed Web of Science ®Google Scholar
• Kiernan UA, Tubbs KA, Nedelkov D, et al. Comparative urine protein phenotyping using mass spectrometric immunoassay. J Proteome Res. 2003;2:191–197.
   PubMed Web of Science ®Google Scholar
• Lopez MF, Rezai T, Sarracino DA, et al. Selected reaction monitoring-mass spectrometric immunoassay responsive to parathyroid hormone and related variants. Clin Chem. 2010;56:281–290.
   PubMed Web of Science ®Google Scholar
• Lu CM, Burton WD, Fitzgerald RL, et al. Mass spectrometric immunoassay for parathyroid hormone-related protein. Anal Chem. 2002;74:5507–5512.
   PubMed Web of Science ®Google Scholar
• Nelson RW, Borges CR. Mass spectrometric immunoassay revisited. J Am Soc Mass Spectrom. 2011;22:960–968.
   PubMed Web of Science ®Google Scholar
• Niederkofler EE, Phillips DA, Krastins B, et al. Targeted selected reaction monitoring mass spectrometric immunoassay for insulin-like growth factor 1. PloS One. 2013;8:e81125.
   PubMed Web of Science ®Google Scholar
• Niederkofler EE, Tubbs KA, Gruber K, et al. Determination of beta-2 microglobulin levels in plasma using a high-throughput mass spectrometric immunoassay system. Anal Chem. 2001;73:3294–3299.
   PubMed Web of Science ®Google Scholar
• Oran PE, Jarvis JW, Borges CR, et al. Mass spectrometric immunoassay of intact insulin and related variants for population proteomics studies. Proteomics Clin Appl. 2011;5:454–459.
   PubMed Web of Science ®Google Scholar
• Peterman S, Niederkofler EE, Phillips DA, et al. An automated, high-throughput method for targeted quantification of intact insulin and its therapeutic analogs in human serum or plasma coupling mass spectrometric immunoassay with high resolution and accurate mass detection (MSIA-HR/AM). Proteomics. 2014;14:1445–1456.
   PubMed Web of Science ®Google Scholar
• Whiteaker JR, Zhao L, Anderson L, et al. An automated and multiplexed method for high throughput peptide immunoaffinity enrichment and multiple reaction monitoring mass spectrometry-based quantification of protein biomarkers. Mol Cell Proteomics. 2010;9:184–196.
   PubMed Web of Science ®Google Scholar
• Whiteaker JR, Zhao L, Lin C, et al. Sequential multiplexed analyte quantification using peptide immunoaffinity enrichment coupled to mass spectrometry. Mol Cell Proteomics. 2012;11:M111 015347.
   PubMed Web of Science ®Google Scholar
• Schneck NA, Phinney KW, Lee SB, et al. Quantification of antibody coupled to magnetic particles by targeted mass spectrometry. Anal Bioanal Chem. 2016;408:8325–8332.
   PubMed Web of Science ®Google Scholar
• Tubbs KA, Nedelkov D, Nelson RW. Detection and quantification of beta-2-microglobulin using mass spectrometric immunoassay. Anal Biochem. 2001;289:26–35.
   PubMed Web of Science ®Google Scholar
• Oran PE, Trenchevska O, Nedelkov D, et al. Parallel workflow for high-throughput (>1,000 samples/day) quantitative analysis of human insulin-like growth factor 1 using mass spectrometric immunoassay. PloS One. 2014;9:e92801.
   PubMed Web of Science ®Google Scholar
• Torre BG, Albericio F. The pharmaceutical industry in 2016. An analysis of FDA drug approvals from a perspective of the molecule type. Molecules. 2017 Feb 27;22(3). pii: E368. doi: 10.3390/molecules22030368.
   Google Scholar
• Navarro P, Kuharev J, Gillet LC, et al. A multicenter study benchmarks software tools for label-free proteome quantification. Nat Biotechnol. 2016;34:1130–1136.
   PubMed Web of Science ®Google Scholar
• MacLean B, Tomazela DM, Shulman N, et al. Skyline: an open source document editor for creating and analyzing targeted proteomics experiments. Bioinformatics. 2010;26:966–968.
   PubMed Web of Science ®Google Scholar